AzTrials
AzTrials

Arthropathy of KneeNCT05853497

A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement

A study testing Multi-Component Weight Loss Intervention in people with Arthropathy of Knee and Obesity, run by University of Kansas Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Obesity, specifically BMIs ≥35 or 40 kg/m2, are associated with an increased probability of poor outcomes of Total Knee Arthroplasty (TKA) including increased pain, risk for infection, poor joint function, and increased rates of hospital readmissions. Read more about this study

Who is it for?
Ages 50 to 75 years
Conditions the study is for
Arthropathy of Knee, Obesity
What is being tested?
Multi-Component Weight Loss Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
1 May 2023to 9 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age: 50-75 years
  • BMI: 35 to ≤40 kg/m2
  • Patient of KU Health System Department of Orthopedics and Sports Medicine (KUOrtho)meeting all requirements for TKA surgery.
  • TKA surgical date scheduled ≥3 mos. from consent
  • Own a Bluetooth enabled computer, tablet, or smart phone with the ability to join remote telehealth sessions and sync study self-monitoring devices.

Who cannot join

  • Weight loss ≥10 pounds in previous 6 months
  • Dairy/milk protein allergy
  • Currently pregnant/breastfeeding or planning to become pregnant during the study
  • Currently being treated for an eating disorder or history of an eating disorder diagnosis
  • Pacemaker
  • Current Cancer
Show all 13Show fewer
  • Diabetes Type 1 (insulin dependent)
  • Hyperuricemia (untreated)
  • Inflammatory bowel disease (active)
  • Liver disease requiring protein restriction
  • Myocardial infarction within last 3 months
  • Abnormal ECG
  • Renal insufficiency.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

Other trials in United States

About this study

Obesity, specifically BMIs ≥35 or 40 kg/m2, are associated with an increased probability of poor outcomes of Total Knee Arthroplasty (TKA) including increased pain, risk for infection, poor joint function, and increased rates of hospital readmissions. Several orthopedic and public health organizations recommend weight loss prior to TJA for individuals with overweight/obesity. However, empirical evidence suggesting the effectiveness of pre-surgical weight loss on surgical and functional outcomes of TKA is extremely limited and is based primarily on non-randomized observational studies. Thus, to gain further insight regarding the feasibility and potential effectiveness of pre-surgical weight loss on outcomes of TKA, the proposed pilot trial will randomize 30 patients (age 50-75 yrs., BMI 35<40 kg/m2) scheduled for TKA through The University of Kansas Health System Department of Orthopedics and Sports Medicine (KUOrtho) to a multi-component weight loss (3-mo. pre-TKA, very low-calorie diet) and maintenance intervention (3-mo. post TKA, conventional maintenance diet) or standard care control which will include no dietary or weight loss advice. The weight loss/maintenance interventions will include reduced energy intake or energy intake prescribed for weight loss maintenance, increased physical activity, and individual behavior counseling. Outcomes will be assessed 1) baseline, i.e., 3 mos. prior to surgery, 2) 3 mos. i.e., at the completion of the weight loss intervention prior to TKA, 3) within a minimum of 2 weeks post TKA, and 4) 3 mos. post-TKA, i.e., after completion of the weight maintenance intervention to assess the feasibility and effectiveness of a remotely delivered multi-component pre-TKA weight loss and a post-TKA weight maintenance intervention.

Being tested
Multi-Component Weight Loss Intervention
Keywords
Total Knee Arthroplasty, Total Knee Replacement
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multi-Component Weight Loss InterventionBehavioural

    The intervention group will receive weekly 1-on-1 health coaching with a very-low calorie nutrition plan prior to total knee replacement and a conventional weight maintenance nutrition plan after surgery.

Study groups in NCT05853497
Study groupRoleWhat they receive
Standard Care ControlNo interventionStandard care
InterventionExperimentalMulti-component weight loss intervention
Receives: Behavioral: Multi-Component Weight Loss Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant Retention Feasibility

    Feasibility will be based on retention of ≥ 80% participants (i.e., <20% participant dropout).

    Measured: 6 Months

  2. Participant Attendance Feasibility

    Feasibility will be based on ≥ 80% attendance at behavioral counseling sessions.

    Measured: 6 Months

Secondary outcomes (5)
  1. Knee and Lower Extremity Physical Function (OARSI Test)

    Knee and lower extremity function will be compared between study arms using the Osteoarthritis Research Society International (OARSI) physical function test battery.

    Measured: 6 Months

  2. Fat Mass (kg)

    Changes in fat mass (kg) will be compared between study arms using dual x-ray absorptiometry (DEXA)

    Measured: 6 Months

  3. Fat Free Mass (kg)

    Changes in fat free mass (kg) will be compared between study arms using dual x-ray absorptiometry (DEXA)

    Measured: 6 Months

  4. Body Weight (kg)

    Changes in body weight (kg) will be compared between study arms using a calibrated body weight scale.

    Measured: 6 Months

  5. Self reported knee function

    Self-reported knee function will be compared between study arms using the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire. Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms.

    Measured: 6 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2023
  2. Study start1 May 2023
  3. Primary completion30 Apr 2025
  4. Study completion9 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05853497
Sponsor's protocol ID
STUDY00149595
Status last verified
Sep 2025
First submitted
6 Mar 2023
Last updated
17 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Multi-Component Weight Loss Intervention in people with Arthropathy of Knee and Obesity, run by University of Kansas Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant Retention Feasibility (time frame: 6 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in